JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

B4950 Darunavir Ethanolate

Summary: nonpeptidic HIV protease inhibitor

≥59.17 mg/mL
A8204 Lopinavir

Summary: HIV protease inhibitor,highly potent

≥31.45 mg/mL
A8205 Atazanavir
1 Citation

Summary: HIV protease inhibitor,highly potent

≥28.6 mg/mL
A4040 Atazanavir sulfate (BMS-232632-05)

Summary: Protease inhibitor

≥28.7 mg/mL
A8203 Ritonavir

Summary: HIV protease inhibitor

≥26 mg/mL
A8206 Darunavir
2 Citation

Summary: HIV-1 protease inhibitor

≥22.65 mg/mL
A8201 Amprenavir (agenerase)

Summary: HIV-1 protease inhibitor
A3253 BMS-626529
2 Citation

Target: HIV-1 gp120

Summary: HIV-1 attachment inhibitor

insoluble in H2O; insoluble in EtOH; ≥1.48 mg/mL
A3421 Fosamprenavir Calcium Salt

Summary: Prodrug of antiretroviral protease inhibitor amprenavir

≥6.66 mg/mL
A3653 Nelfinavir Mesylate

Summary: HIV protease inhibitor,antiretroviral drug for HIV treatment

≥66.4 mg/mL